Chemistry and biology of kahalalides.
作者信息
Gao Jiangtao, Hamann Mark T
机构信息
Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, University, Mississippi 38677, USA.
出版信息
Chem Rev. 2011 May 11;111(5):3208-35. doi: 10.1021/cr100187n. Epub 2011 Apr 11.
Abstract
摘要
相似文献
1
Chemistry and biology of kahalalides.
Chem Rev. 2011 May 11;111(5):3208-35. doi: 10.1021/cr100187n. Epub 2011 Apr 11.
2
Synthesis of Natural and Unnatural Cyclooligomeric Depsipeptides Enabled by Flow Chemistry.
Chemistry. 2016 Mar 14;22(12):4206-17. doi: 10.1002/chem.201504457. Epub 2016 Feb 4.
3
Phytoplankton of the Curonian Lagoon as a New Interesting Source for Bioactive Natural Products. Special Impact on Cyanobacterial Metabolites.
Biomolecules. 2021 Aug 2;11(8):1139. doi: 10.3390/biom11081139.
4
Chemistry and biology of cyclic depsipeptides of medicinal and biological interest.
Curr Med Chem. 2004 May;11(10):1309-32. doi: 10.2174/0929867043365224.
5
Marine Depsipeptides as Promising Pharmacotherapeutic Agents.
Curr Protein Pept Sci. 2017;18(1):72-91. doi: 10.2174/1389203717666160526122130.
6
Revisiting N-to-O acyl shift for synthesis of natural product-like cyclic depsipeptides.
Org Lett. 2014 Dec 5;16(23):6088-91. doi: 10.1021/ol503170b. Epub 2014 Nov 20.
7
Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
Bioorg Med Chem Lett. 2008 Aug 1;18(15):4385-7. doi: 10.1016/j.bmcl.2008.06.066. Epub 2008 Jun 21.
8
[Biologically active nonribosomal peptides. II. Nonribosomal peptides of various biological action].
Antibiot Khimioter. 2011;56(11-12):30-3.
9
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
J Nat Prod. 2008 Mar;71(3):438-44. doi: 10.1021/np700738k. Epub 2008 Mar 8.
10
Tasipeptins A and B: new cytotoxic depsipeptides from the marine cyanobacterium Symploca sp.
J Nat Prod. 2003 May;66(5):620-4. doi: 10.1021/np020582t.
引用本文的文献
1
Characterizing the evolution of defense in a tripartite marine symbiosis using adaptive dynamics.
Evol Lett. 2024 Oct 20;9(1):105-114. doi: 10.1093/evlett/qrae052. eCollection 2025 Feb.
2
New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions.
J Fungi (Basel). 2024 Dec 15;10(12):871. doi: 10.3390/jof10120871.
3
Recent Advances in Marine-Derived Compounds as Potent Antibacterial and Antifungal Agents: A Comprehensive Review.
Mar Drugs. 2024 Jul 29;22(8):348. doi: 10.3390/md22080348.
4
Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents.
Mar Drugs. 2023 Nov 25;21(12):609. doi: 10.3390/md21120609.
5
Occurrence of D-amino acids in natural products.
Nat Prod Bioprospect. 2023 Nov 7;13(1):47. doi: 10.1007/s13659-023-00412-0.
6
Non-Canonical Amino Acids as Building Blocks for Peptidomimetics: Structure, Function, and Applications.
Biomolecules. 2023 Jun 12;13(6):981. doi: 10.3390/biom13060981.
7
Solonamides, a Group of Cyclodepsipeptides, Influence Motility in the Native Producer Photobacterium galatheae S2753.
Appl Environ Microbiol. 2022 Sep 13;88(17):e0110522. doi: 10.1128/aem.01105-22. Epub 2022 Aug 24.
8
Recent advances and limitations in the application of kahalalides for the control of cancer.
Biomed Pharmacother. 2022 Apr;148:112676. doi: 10.1016/j.biopha.2022.112676. Epub 2022 Feb 8.
9
Bioactive Compounds from Marine Heterobranchs.
Mar Drugs. 2020 Dec 21;18(12):657. doi: 10.3390/md18120657.
10
Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways.
Mol Biol Rep. 2020 Sep;47(9):7209-7228. doi: 10.1007/s11033-020-05709-8. Epub 2020 Aug 14.
本文引用的文献
1
5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor.
J Nat Prod. 2009 Dec;72(12):2172-6. doi: 10.1021/np900287e.
2
Cancer treatments: can we find treasures at the bottom of the sea?
Clin Lung Cancer. 2009 Jul;10(4):295-300. doi: 10.3816/CLC.2009.n.041.
3
Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models.
Eur J Cancer. 2009 Jul;45(10):1855-64. doi: 10.1016/j.ejca.2009.03.003. Epub 2009 Apr 5.
4
Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agents.
Mol Pharm. 2009 May-Jun;6(3):813-24. doi: 10.1021/mp8001039.
5
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma.
Eur J Cancer. 2009 Mar;45(5):732-5. doi: 10.1016/j.ejca.2008.12.005. Epub 2009 Jan 29.
6
Drug development from marine natural products.
Nat Rev Drug Discov. 2009 Jan;8(1):69-85. doi: 10.1038/nrd2487. Epub 2008 Dec 19.
7
Conjugation of Kahalalide F with gold nanoparticles to enhance in vitro antitumoral activity.
Bioconjug Chem. 2009 Jan;20(1):138-46. doi: 10.1021/bc800362j.
8
Levels of SCS7/FA2H-mediated fatty acid 2-hydroxylation determine the sensitivity of cells to antitumor PM02734.
Cancer Res. 2008 Dec 1;68(23):9779-87. doi: 10.1158/0008-5472.CAN-08-1981.
9
Horizontal gene transfer of the algal nuclear gene psbO to the photosynthetic sea slug Elysia chlorotica.
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17867-71. doi: 10.1073/pnas.0804968105. Epub 2008 Nov 11.
10
Natural products in drug discovery.
Drug Discov Today. 2008 Oct;13(19-20):894-901. doi: 10.1016/j.drudis.2008.07.004. Epub 2008 Aug 22.
Zotero 插件